Details
Product Name in the RMS: Cloreto de Potássio + Cloreto de Sódio Kabi
MR Number: PT/H/1153/001
Date of outcome: 25.06.2014
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Initial Application Generic Chemical Substance Prescription Only |
Active Substances |
potassium chloride 15 mg sodium chloride 9 mg |
Form | Solution for infusion |
MA Holder in the RMS | Freseniuns Kabi Pharma Portugal, Lda |
RMS | Portugal |
Date of last change | 04.02.2019 |
ATC-Code |
B05BB01 Electrolytes |
CMS Country | Domestic Product Name |
---|---|
Belgium | KCl 0.15% w/v + NaCl 0.9% w/v Fresenius Kabi, oplossing voor infusie |
Estonia | POTASSIUM CHLORIDE/SODIUM CHLORIDE FRESENIUS |
France | |
Ireland | |
Latvia | Potassium Chloride/ Sodium Chloride Fresenius 1,5 mg/9 mg/ml šķīdums infūzijām |
Lithuania | Potassium Chloride/Sodium Chloride Fresenius 1,5 mg/9 mg/ml infuzinis tirpalas |
Netherlands | Kaliumchloride 0.15% w/v - Natriumchloride 0.9% w/v Fresenius Kabi, oplossing voor infusie |
Poland | |
Slovenia | |
Spain | |
United Kingdom |
Documents | |
---|---|
PAR: | PT_H_1153_001_PAR.pdf (28.08.2014) |
Finalised Product Information: | PT_H_1153_001_FinalPI_1of8.pdf (26.06.2014) |
Finalised Product Information: | PT_H_1153_001_FinalPI_2of8.pdf (26.06.2014) |
Finalised Product Information: | PT_H_1153_001_FinalPI_3of8.pdf (26.06.2014) |
Finalised Product Information: | PT_H_1153_001_FinalPI_4of8.pdf (26.06.2014) |
Finalised Product Information: | PT_H_1153_001_FinalPI_5of8.pdf (26.06.2014) |
Finalised Product Information: | PT_H_1153_001_FinalPI_6of8.pdf (26.06.2014) |
Finalised Product Information: | PT_H_1153_001_FinalPI_7of8.pdf (26.06.2014) |
Finalised Product Information: | PT_H_1153_001_FinalPI_8of8.pdf (26.06.2014) |